previous
demonstr
antigen
chemic
coupl
surfac
liposom
consist
unsatur
fatti
acid
crosspres
antigen
present
cell
cytotox
lymphocyt
ctl
liposom
form
immunodomin
ctl
epitop
peptid
deriv
lymphocyt
choriomening
viru
exhibit
highli
effici
antivir
ctl
respons
immun
mice
studi
coupl
highli
conserv
immunodomin
ctl
epitop
peptid
deriv
hepat
c
viru
hcv
surfac
liposom
also
emulsifi
peptid
incomplet
freund
adjuv
compar
immun
respons
two
method
present
peptid
cytotox
induct
interferongamma
ifnc
product
cell
immun
mice
notic
signific
variat
immunogen
peptid
two
antigen
deliveri
system
addit
immunogen
profil
peptid
also
differ
observ
mice
infect
recombin
adenovirus
express
hcv
protein
previous
report
induct
antivir
immun
liposom
peptid
test
challeng
experi
use
recombin
vaccinia
virus
express
correspond
hcv
epitop
one
b
restrict
three
hlaa
hcv
ctl
epitop
peptid
surfac
liposom
found
confer
complet
protect
immun
mice
establish
longterm
memori
interestingli
protect
efficaci
seem
correl
induct
ifnc
produc
cell
rather
cytotox
induct
suggest
immun
mice
protect
noncytolyt
mechan
thu
liposom
peptid
might
use
hcv
vaccin
prevent
also
therapeut
use
hepat
c
viru
hcv
caus
persist
infect
half
infect
patient
often
lead
develop
cirrhosi
hepatocellular
carcinoma
pegyl
interferon
ribavirin
therapi
although
benefici
half
treat
patient
expens
associ
signific
side
effect
clinic
context
urgent
need
develop
therapeut
andor
prophylact
hcv
vaccin
well
document
major
histocompat
complex
mhc
class
irestrict
cytotox
lymphocyt
ctl
play
major
role
immun
control
variou
viru
infect
case
hcv
infect
spontan
resolut
acut
hcv
infect
associ
vigor
hcvspecif
ctl
respons
chimpanze
human
henc
hcvspecif
ctl
like
crucial
erad
hcv
previous
demonstr
antigen
chemic
coupl
surfac
liposom
consist
unsatur
fatti
acid
crosspres
antigen
present
cell
apc
ctl
coupl
liposom
immunodomin
ctl
epitop
peptid
deriv
lymphocyt
choriomening
viru
lcmv
exhibit
highli
effici
antivir
respons
immun
mice
singl
immun
low
ng
liposom
peptid
along
cpg
confer
complet
protect
immun
mice
also
effect
highli
virul
mutant
strain
clone
addit
longterm
memori
induct
achiev
absenc
cell
help
form
ctlbase
liposom
vaccin
also
develop
sar
coronaviru
influenza
viru
effect
enough
protect
mice
heterosubtyp
influenza
virus
previous
evalu
hlaa
hcvderiv
epitop
examin
peptidebind
affin
hlaa
molecul
stabil
peptidehlaa
complex
kill
activ
ctl
frequenc
intracellular
interferongamma
ifnc
posit
cell
induc
mice
immun
hcv
proteinexpress
recombin
adenovirus
basi
result
peptid
test
classifi
six
group
studi
chose
peptid
five
group
coupl
well
one
murin
mhcrestrict
hcv
ctl
epitop
peptid
surfac
liposom
also
emulsifi
peptid
incomplet
freund
adjuv
ifa
compar
immunogen
analyz
cytolyt
activ
number
ifncproduc
cell
induc
immun
mice
liposom
peptid
test
protect
efficaci
challeng
experi
mice
purchas
tokyo
laboratori
anim
scienc
co
ltd
tokyo
japan
knockout
ko
mice
background
purchas
jackson
laboratori
bar
harbor
transgen
mice
hhd
kind
gift
dr
f
lemonni
pasteur
institut
pari
franc
express
transgen
hlaa
monochain
human
microglobulin
coval
link
chimer
heavi
chain
compos
hlaa
domain
b
transmembran
cytoplasm
domain
sixto
mice
use
experi
mice
hous
appropri
anim
care
facil
saitama
medic
univers
saitama
japan
handl
accord
intern
guidelin
experiment
protocol
approv
anim
research
committe
saitama
medic
school
mous
lymphoma
cell
line
obtain
atcc
african
green
monkeyderiv
kidney
cell
line
provid
dr
shioda
osaka
univers
osaka
japan
cell
line
cultur
dmem
fc
mous
lymphoma
cell
line
transfect
hhd
gene
rmahhd
maintain
contain
sigmaaldrich
st
loui
mo
final
concentr
lgml
peptid
list
tabl
peptid
tppayrppnapil
synthes
operon
biotechnolog
tokyo
japan
synthet
cpg
odn
tccatgacgttcttgatgtt
purchas
hokkaido
system
scienc
sapporo
japan
phoshorothio
protect
avoid
nucleasedepend
degrad
oleoyl
liposom
consist
dioleoyl
phosphatidyl
cholin
dioleoyl
phosphatidyl
ethanolamin
dioleoyl
phosphatidyl
glycerol
acid
cholesterol
ratio
peptid
coupl
surfac
liposom
via
disuccinimidyl
suber
describ
previous
final
prepar
contain
mg
less
peptid
mg
liposom
per
ml
gener
recombin
vaccinia
viru
express
hcv
core
vvcore
describ
recombin
vaccinia
virus
express
hcv
gener
describ
brief
hcv
gene
correspond
amino
acid
residu
respect
amplifi
plasmid
contain
entir
dna
sequenc
deriv
hcv
clone
kindli
provid
dr
charl
rice
rockefel
univers
new
york
ny
pcr
insert
transfer
vector
recombin
vaccinia
virus
gener
homolog
recombin
wildtyp
vaccinia
viru
vvwt
wr
strain
transfer
vector
purifi
cell
propag
cell
mous
subcutan
sc
immun
either
liposom
peptid
indic
amount
togeth
lg
cpg
pb
peptid
lg
emulsifi
ifa
peptid
lg
crreleas
assay
carri
describ
brief
spleen
cell
immun
mice
cultur
seven
day
irradi
gy
syngen
naiv
spleen
cell
prepuls
lm
relev
peptid
employ
effector
cell
standard
crreleas
assay
target
cell
puls
without
lm
peptid
h
label
na
cro
h
label
target
cell
plate
effector
cell
effector
target
et
ratio
incub
radioact
supernat
count
percent
lysi
calcul
cpm
sampl
spontan
cpm
maximum
spontan
maximum
cr
releas
determin
supernat
cell
lyse
addit
nonidet
spontan
releas
measur
supernat
target
cell
incub
without
effector
cell
percent
specif
lysi
calcul
subtract
percent
lysi
unpuls
target
peptidepuls
target
detect
ifnc
secret
cell
perform
use
mous
ifnc
enzymelink
immunospot
elispot
set
bd
pharmingen
san
diego
ca
describ
abbrevi
na
applic
classif
hcvderiv
ctl
epitop
determin
previou
studi
type
high
medium
affin
high
medium
lysi
high
medium
intracellular
cytokin
stain
ic
ifnc
type
ii
high
medium
affin
high
medium
lysi
low
nd
ic
type
iii
low
affin
high
lysi
type
iv
high
affin
low
nd
lysi
medium
ic
type
v
high
medium
affin
low
nd
lysi
low
nd
ic
type
vi
low
affin
nd
lysi
ic
nd
detect
immun
mice
challeng
ip
pfu
vvcore
five
day
later
mice
sacrif
titer
homogen
two
ovari
mous
determin
cell
describ
titrat
perform
duplic
averag
pfu
per
mous
calcul
statist
analys
perform
student
test
valu
p
consid
statist
signific
observ
murin
mhc
b
restrict
hcv
ctl
epitop
show
much
higher
immunogen
human
hlaa
hcv
ctl
epitop
hhd
mice
infect
recombin
adenoviru
express
hcv
unpublish
data
therefor
first
chose
peptid
made
two
vaccin
surfacelink
liposom
peptid
peptid
emulsifi
ifa
mhc
class
ii
pan
helper
peptid
immunogen
two
form
peptid
compar
analyz
spleen
cell
immun
mice
cytotox
ifnc
product
crreals
assay
fig
elispot
assay
fig
respect
notic
induc
signific
higher
respons
assay
immun
mice
challeng
recombin
vaccinia
viru
found
induc
steril
immun
mice
wherea
show
signific
effect
fig
steril
immun
confer
could
observ
even
week
immun
fig
longterm
memori
confirm
strong
recal
respons
observ
week
postimmun
elispot
ifnc
assay
fig
memori
induct
also
observ
ko
mice
fig
suggest
carri
without
cell
help
previous
shown
liposom
lcmv
peptid
doserespons
elispot
ifnc
assay
reveal
low
ng
could
induc
signific
ifnc
respons
fig
highli
effici
induct
ifncproduc
cell
similar
observ
among
hlaa
hcv
ctl
epitop
peptid
character
immunogen
classifi
six
group
previou
studi
peptid
tabl
chosen
coupl
surfac
liposom
emulsifi
ifa
immun
sc
hhd
mous
peptid
twice
one
week
second
immun
spleen
cell
test
crreals
assay
fig
elispot
assay
fig
type
peptid
iv
tabl
determin
immunogen
mice
endogen
express
hcv
protein
infect
recombin
adenovirus
shown
fig
comparison
consider
variabl
immunogen
observ
peptid
also
mode
antigen
deliveri
accord
three
assay
result
peptid
observ
fig
b
induct
antivir
activ
test
liposom
peptid
challeng
experi
recombin
vaccinia
virus
express
correspond
epitop
among
exhibit
complet
protect
reproduc
least
three
independ
experi
other
show
insignific
partial
nonreproduc
protect
fig
notabl
three
liposom
peptid
confer
perfect
protect
belong
highest
induc
ifnc
cell
fig
induc
high
cytolyt
activ
poor
ifnc
respons
cell
show
partial
nonreproduc
protect
show
excel
antivir
effector
cell
induct
also
analyz
abil
longterm
memori
induct
memori
week
postimmun
induc
three
strong
induc
ifnc
complet
protect
mice
challeng
poor
induc
ifnc
exhibit
signific
titer
reduct
fig
memori
induct
confirm
recal
respons
elispot
ifnc
assay
fig
correl
well
result
challeng
experi
fig
report
demonstr
hcvderiv
antigen
peptid
coupl
surfac
liposom
serv
effici
vaccin
vehicl
induct
antivir
immun
mediat
cell
previous
shown
lcmvderiv
peptid
immun
induc
signific
level
cytotox
ifncproduc
cell
steril
immun
immun
mice
fig
doserespons
elispot
assay
reveal
could
induc
signific
respons
less
ng
peptid
fig
similar
observ
longterm
memori
induct
also
confirm
week
immun
seem
independ
cell
help
fig
fig
howev
studi
show
clearli
qualit
quantit
immun
respons
induc
peptid
coupl
surfac
liposom
may
differ
peptid
emulsifi
mhc
class
ii
pan
helper
peptid
ifa
induc
lower
respons
crreleas
fig
elispot
assay
fig
compar
show
signific
protect
challeng
experi
fig
hlaa
hcv
epitop
peptid
also
show
consider
differ
immunogen
liposom
emuls
form
fig
b
peptid
ifa
induc
cytolyt
ifnc
respons
wherea
peptid
surfac
liposom
predominantli
induc
cytolyt
activ
hand
show
opposit
result
mainli
induc
cytolyt
respons
induc
strong
ifnc
respons
rather
cytolyt
respons
liposom
show
strong
respons
assay
wherea
ifa
induc
cytolyt
respons
found
strong
induc
cytolyt
activ
emulsifi
ifa
surfac
liposom
induc
neither
cytolyt
ifnc
respons
hlaa
hcv
epitop
peptid
surfac
liposom
test
efficaci
induc
protect
viru
challeng
exhibit
perfect
reproduc
protect
fig
interestingli
three
liposom
peptid
strongest
induc
ifnc
respons
fig
contrast
found
induc
nonreproduc
protect
titer
reduct
less
two
log
although
strong
induc
cytolyt
activ
line
evid
suggest
antivir
activ
induc
liposom
peptid
mediat
noncytolyt
mechan
relat
ifnc
respons
similar
observ
obtain
previou
studi
lcmvderiv
b
restrict
epitop
peptid
liposom
induc
strong
ifnc
respons
cytolyt
respons
mice
highli
protect
lcmv
challeng
lcmv
hcv
report
suscept
noncytolyt
antivir
mechan
taken
togeth
peptid
surfac
liposom
may
advantag
applic
therapeut
use
virusinfect
cell
may
elimin
without
tissu
damag
studi
need
clarifi
issu
specul
mechan
underli
induct
differ
immunogen
peptid
coupl
surfac
liposom
associ
differ
antigen
present
mechan
peptid
emulsifi
ifa
thought
fit
pocket
mhc
class
molecul
apc
replac
origin
endogen
synthes
peptid
present
cell
hand
shown
antigen
chemic
coupl
surfac
liposom
consist
unsatur
fatti
acid
oleoyl
liposom
crosspres
apc
studi
shown
oleoyl
liposom
might
taken
apc
via
least
two
pathway
fusion
penetr
plasma
membran
pinocytosi
uniqu
antigen
present
mechan
may
respons
uniqu
immunogen
antivir
potenc
peptid
antigen
hlaa
epitop
peptid
character
immunogen
previou
studi
analyz
immun
respons
mice
immun
recombin
adenovirus
express
hcv
protein
immunogen
profil
respons
adenovirusvector
cproduc
cell
respond
relev
peptid
detect
elispot
assay
group
number
iv
epitop
classifi
previou
studi
tabl
immun
quit
differ
obtain
two
type
peptid
vaccin
fig
b
adenoviru
vaccin
peptid
endogen
synthes
present
mhc
class
molecul
virusinfect
cell
therefor
immunogen
profil
induc
third
antigen
present
mechan
may
also
support
hypothesi
differ
immun
system
result
differ
antigen
present
therefor
differ
immun
respons
conclus
coupl
peptid
antigen
surfac
liposom
consist
unsatur
fatti
acid
seem
give
rise
uniqu
immun
respons
profil
peptid
hcv
peptideliposom
may
use
prophylact
therapeut
vaccin
